2019
DOI: 10.1111/jns.12352
|View full text |Cite
|
Sign up to set email alerts
|

Hereditary sensory autonomic neuropathy type II: Report of two novel mutations in the FAM134B gene

Abstract: Hereditary sensory autonomic neuropathy (HSAN) type II is a rare, autosomal recessive, and early onset sensory neuropathy, characterized by severe and progressive sensation impairment, leading to ulcero‐mutilating complications. FAM134B gene, also known as RETREG1 gene, mutations have been reported to be associated to HSAN‐IIB. We report four patients from two unrelated families who developed during childhood a sensory axonal neuropathy with variable severity and pronounced nociception impairment. Complication… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 10 publications
0
15
0
Order By: Relevance
“…FAM134B, including a 2-bp deletion causing a frameshift (p.P7GfsX133), a nonsense mutation (p.Q145X), and a mutation in the splice-donor consensus site of intron 7 (c.873 + 2 T > C) 8 . Afterward, many case reports show the same or different FAM134B mutations in patients with HSAN II [59][60][61][62][63] . For a more intuitive overview, we summarize some mutations of FAM134B in HSAN II in Table 1.…”
Section: Neuropathymentioning
confidence: 99%
“…FAM134B, including a 2-bp deletion causing a frameshift (p.P7GfsX133), a nonsense mutation (p.Q145X), and a mutation in the splice-donor consensus site of intron 7 (c.873 + 2 T > C) 8 . Afterward, many case reports show the same or different FAM134B mutations in patients with HSAN II [59][60][61][62][63] . For a more intuitive overview, we summarize some mutations of FAM134B in HSAN II in Table 1.…”
Section: Neuropathymentioning
confidence: 99%
“…HSAN2 has four subtypes defined by molecular etiology: HSAN2A ( WNK1 , MIM# 201300), HSAN2B ( RETREG1, formerly known as FAM134B , MIM# 613115), HSAN2C ( KIF1A , MIM# 614213), and HSAN2D ( SCN9A , MIM# 243000) (Kurth 1993). Although there is no clear clinical distinction among subtypes, autonomic disorders may be especially prominent in HSAN2B caused by biallelic loss‐of‐function (LoF) variants in RETREG1 (Falcao de Campos et al, 2019; Kurth et al, 2009; Wakil et al, 2018). RETREG1 encodes a cis ‐Golgi transmembrane endoplasmic reticulum (ER) receptor regulating the ER turnover through reticulophagy (Islam et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Although there is no clear clinical distinction among subtypes, autonomic disorders may be especially prominent in HSAN2B caused by biallelic loss-of-function (LoF) variants in RETREG1 (Falcao de Campos et al, 2019;Kurth et al, 2009;Wakil et al, 2018). RETREG1 encodes a cis-Golgi transmembrane endoplasmic reticulum (ER) receptor regulating the ER turnover through reticulophagy (Islam et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Leg spasticity and weakness has been reported in some HSAN patients, which suggests involvement and degeneration of axons of upper motoneurons (Eggermann et al, 2018). Mutations in FAM134B are closely related to HSANIIB (Davidson et al, 2012; Falcão de Campos et al, 2019; Kurth et al, 2009; Luo et al, 2021; Murphy et al, 2012; Park et al, 2019; Tarailo‐Graovac et al, 2019; Taşdelen et al, 2022; Wakil et al, 2018; Zhu et al, 2021). Patients with this HSAN subtype develop autonomic dysfunction and impaired nociception, with extreme cases resulting in severe mutilation (Zhu et al, 2021).…”
Section: Cytoplasmic Receptorsmentioning
confidence: 99%